Kathy Parisi

746 total citations
17 papers, 521 citations indexed

About

Kathy Parisi is a scholar working on Molecular Biology, Microbiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kathy Parisi has authored 17 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Microbiology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kathy Parisi's work include Antimicrobial Peptides and Activities (8 papers), Biochemical and Structural Characterization (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Kathy Parisi is often cited by papers focused on Antimicrobial Peptides and Activities (8 papers), Biochemical and Structural Characterization (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Kathy Parisi collaborates with scholars based in Australia, United States and United Kingdom. Kathy Parisi's co-authors include Mark R. Bleackley, Nicole L. van der Weerden, Marilyn A. Anderson, Thomas Shafee, Pedro Quimbar, Joanne L. Casey, Michael Foley, Andrew M. Coley, Karen S. Harris and Adrian H. Batchelor and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Kathy Parisi

17 papers receiving 509 citations

Peers

Countries citing papers authored by Kathy Parisi

Since Specialization

Citations

This map shows the geographic impact of Kathy Parisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Parisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Parisi more than expected).

Fields of papers citing papers by Kathy Parisi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Parisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Parisi. The network helps show where Kathy Parisi may publish in the future.

Co-authorship network of co-authors of Kathy Parisi

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Parisi. A scholar is included among the top collaborators of Kathy Parisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Parisi. Kathy Parisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Hyperpolarisation of Mitochondrial Membranes Is a Critical Component of the Antifungal Mechanism of the Plant Defensin, Ppdef1 2024 ·Journal of Fungi ·Kathy Parisi, James A. McKenna, Rohan G. T. Lowe, Karen S. Harris, Thomas Shafee, Rosemary F. Guarino, (unknown), Nicole L. van der Weerden, Mark R. Bleackley, Marilyn A. Anderson	11
2	Aggregation-prone antimicrobial peptides target gram-negative bacterial nucleic acids and protein synthesis 2024 ·Acta Biomaterialia ·(unknown), Tianmeng Zhang, Chunyuan Li, (unknown), Kathy Parisi, (unknown), Siyang Ding, John D. Wade, Yuning Hong, Sihui Li, Jackson Nkoh Nkoh, Andrew Hung, Wenyi Li, Chenjing Shang	12
3	The Plant Defensin Ppdef1 Is a Novel Topical Treatment for Onychomycosis 2023 ·Journal of Fungi ·Nicole L. van der Weerden, Kathy Parisi, James A. McKenna, (unknown), Peta J. Harvey, Pedro Quimbar, (unknown), Prem K. Veneer, (unknown), (unknown), Rosemary F. Guarino, Simon Poon, Yolanda M. Gaspar, Michael J. Baker, David J. Craik, (unknown), Marc B. Brown, Mark R. Bleackley, Marilyn A. Anderson	9
4	32994 Pezadeftide is a potent antifungal peptide with rapid fungicidial activity via a unique mechanism of action 2022 ·Journal of the American Academy of Dermatology ·Nicole L. van der Weerden, James T Mckenna, Kathy Parisi	2
5	Improving the Digestibility of Plant Defensins to Meet Regulatory Requirements for Transgene Products in Crop Protection 2020 ·Frontiers in Plant Science ·Kathy Parisi, Simon Poon, (unknown), (unknown), James J. English, Nasser Yalpani, Mark R. Bleackley, Marilyn A. Anderson, Nicole L. van der Weerden	7
6	Screening the Saccharomyces cerevisiae Nonessential Gene Deletion Library Reveals Diverse Mechanisms of Action for Antifungal Plant Defensins 2019 ·Antimicrobial Agents and Chemotherapy ·Kathy Parisi, Stephen R. Doyle, (unknown), Rohan G. T. Lowe, Nicole L. van der Weerden, Marilyn A. Anderson, Mark R. Bleackley	6
7	Salt-Tolerant Antifungal and Antibacterial Activities of the Corn Defensin ZmD32 2019 ·Frontiers in Microbiology ·(unknown), James A. McKenna, Peta J. Harvey, Pedro Quimbar, Donovan Garcia‐Ceron, Fung T. Lay, Thanh Kha Phan, Prem K. Veneer, (unknown), Kathy Parisi, Thomas Shafee, Nicole L. van der Weerden, Mark D. Hulett, David J. Craik, Marilyn A. Anderson, Mark R. Bleackley	61
8	Ptychographic imaging of NaD1 induced yeast cell death 2019 ·Biomedical Optics Express ·(unknown), Connie Darmanin, Mark R. Bleackley, Kathy Parisi, Guido Cadenazzi, (unknown), Marilyn A. Anderson, K. Nugent, Brian Abbey	6
9	The evolution, function and mechanisms of action for plant defensins 2018 ·Seminars in Cell and Developmental Biology ·Kathy Parisi, Thomas Shafee, Pedro Quimbar, Nicole L. van der Weerden, Mark R. Bleackley, Marilyn A. Anderson	166
10	Bovine pancreatic trypsin inhibitor is a new antifungal peptide that inhibits cellular magnesium uptake 2014 ·Molecular Microbiology ·Mark R. Bleackley, (unknown), Kathy Parisi, (unknown), Ana Traven, Ian D. Potter, Nicole L. van der Weerden, Marilyn A. Anderson	18
11	Shark Variable New Antigen Receptor (VNAR) Single Domain Antibody Fragments: Stability and Diagnostic Applications 2013 ·SHILAP Revista de lepidopterología ·(unknown), Olan Dolezal, Kathy Parisi, (unknown), Con Dogovski, (unknown), (unknown), Joanne L. Casey, Iveth J. González, Matthew A. Perugini, Stewart D. Nuttall, Michael Foley	50
12	Peptides specific for Mycobacterium avium subspecies paratuberculosis infection: diagnostic potential 2011 ·Protein Engineering Design and Selection ·Joanne L. Casey, (unknown), (unknown), (unknown), (unknown), Kathy Parisi, Andrew M. Coley, David J. Stewart, Jill Vaughan, Wojtek P. Michalski, Richard K.J. Luke, Michael Foley	5
13	Peptide mimics selected from immune sera using phage display technology can replace native antigens in the diagnosis of Epstein-Barr virus infection 2008 ·Protein Engineering Design and Selection ·Joanne L. Casey, Andrew M. Coley, Kathy Parisi, Michael Foley	17
14	Display of a Peptide Mimotope on a Crystalline Bacterial Cell Surface Layer (S-layer) Lattice for Diagnosis of Epstein–Barr Virus Infection 2008 ·Bioconjugate Chemistry ·(unknown), Joanne L. Casey, Kathy Parisi, Michael Foley, Uwe B. Sleytr	21
15	The Most Polymorphic Residue on Plasmodium falciparum Apical Membrane Antigen 1 Determines Binding of an Invasion-Inhibitory Antibody 2006 ·Infection and Immunity ·Andrew M. Coley, Kathy Parisi, (unknown), (unknown), Joanne L. Casey, Vincent J. Murphy, Karen S. Harris, Adrian H. Batchelor, Robin F. Anders, Michael Foley	97
16	Peptide Mimotopes Selected from a Random Peptide Library for Diagnosis of Epstein-Barr Virus Infection 2006 ·Journal of Clinical Microbiology ·Joanne L. Casey, Andrew M. Coley, G. Street, Kathy Parisi, Peter L. Devine, Michael Foley	21
17	Mimotopes of Apical Membrane Antigen 1: Structures of Phage-Derived Peptides Recognized by the Inhibitory Monoclonal Antibody 4G2dc1 and Design of a More Active Analogue 2006 ·Infection and Immunity ·Jennifer K. Sabo, David W. Keizer, (unknown), Joanne L. Casey, Kathy Parisi, Andrew M. Coley, Michael Foley, Raymond S. Norton	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact